Details

Industries

Asset Management,Impact Investing

Founded date

Mar 1, 2008

Operating Status

Active

Investor Type

Angel Group

GBP was founded in March 2008 by Professor Andy Porter and Drs Keith Charlton and Gillian Broadbent. GBP is an angel investment group that specialises in seed funding early stage life-science companies. Typical investments are of the order of £50-200k. This grouping is unusual because its internationally recognised scientific team is used by other agencies and investment groups to carry out scientific due diligence prior to their investment.GBP became a Scottish co-investment partner on 1st April 2010. To date the company has made ten investments in Scotland and one in a Malaysian company looking to relocate part of its business to Scotland.The company's major commercial and science focus covers immuno-diagnostics and devices, immuno-technology, biologic drug discovery. GBP has particular expertise in the areas of antibody diagnostics and biologic therapeutics. More recently it has also made early stage assessments and investments in regenerative medicine and vaccine/drug delivery companies.